The microbiome of the oral mucosa in irritable bowel syndrome/Experiment 1
From BugSigDB
Reviewed Marked as Reviewed by Fatima on 2021/07/16
Subjects
- Location of subjects
- United States of America
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Buccal mucosa
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- control
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- irritable bowel syndrome
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- IBS are who suffered from chronic visceral pain and altered bowel habits for more than 6 months for which no organic cause had been identified
- Group 0 sample size Number of subjects in the control (unexposed) group
- 20
- Group 1 sample size Number of subjects in the case (exposed) group
- 9
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- Not specified
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- PhyloChip
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- raw counts
- Statistical test
- Welch's T-Test
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
- Matched on Factors on which subjects have been matched on in a case-control study
- age, body weight, race, sex
Signature 1
Needs review
Source: Figure 6
Description: OTUs showed significant differential abundance between healthy controls and IBS participants
Abundance in Group 1: increased abundance in irritable bowel syndrome
| NCBI | Quality Control | Links |
|---|---|---|
| Prevotella | ||
| Clostridium | ||
| Desulfosporosinus | ||
| Peptostreptococcus | ||
| Alcaligenes | ||
| Burkholderia | ||
| Neisseria |
Revision editor(s): WikiWorks
Signature 2
Needs review
Source: Figure 6
Description: OTUs showed significant differential abundance between healthy controls and IBS participants
Abundance in Group 1: decreased abundance in irritable bowel syndrome
| NCBI | Quality Control | Links |
|---|---|---|
| Corynebacterium | ||
| Propionibacterium | ||
| Streptococcus | ||
| Sphingomonas | ||
| Pseudomonas |
Revision editor(s): WikiWorks
